부산대학교 도서관

Geyer, CEJ; Garber, JE; Gelber, RD; Yothers, G; Taboada, M; Ross, L; Rastogi, P; Cui, K; Arahmani, A; Aktan, G

ANNALS OF ONCOLOGY. 33(12):1250-1268

Weiss A; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; now with Division of Surgical Oncology, Department of Surgery, University of Rochester, Rochester, New York.; Braun D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Stopfer J; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zhao J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; McGrath M; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Bradshaw KR; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Rosito MS; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Davis D; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Garber JE; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; now with Winship Cancer Institute of Emory University, Atlanta, Georgia.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Peshkin BN; Isaacs C

Oncology (08909091) (ONCOLOGY (08909091)), Oct2005; 19(11): 1451-1459. (9p)

Narod, SA; Dube, MP; Klijn, J; Lubinski, J; Lynch, HT; Ghadirian, P; Provencher, D; Heimdal, K; Moller, P; Robson, M; Offit, K; Isaacs, C; Weber, B; Friedman, E; Gershoni-Baruch, R; Rennert, G; Pasini, B; Wagner, T; Daly, M; Garber, JE; Neuhausen, SL; Ainsworth, P; Olsson, Håkan; Evans, G; Osborne, M; Couch, F; Foulkes, WD; Warner, E; Kim-Sing, C; Olopade, O; Tung, N; Saal, HM; Weitzel, J; Merajver, S; Gauthier-Villars, M; Jernström, Helena; Sun, P; Brunet, JS

Journal of the National Cancer Institute. 94(23):1773-1779

Tung NM; Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA.; Robson ME; Memorial Sloan-Kettering Cancer Center, New York, NY.; Li T; Dana-Farber Cancer Institute, Boston, MA.; Nanda R; The University of Chicago, Chicago, IL.; Shah PD; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA.; Khoury K; University of Alabama at Birmingham, Birmingham, AL.; Kimmick G; Duke University Medical Center, Durham, NC.; Santa-Maria C; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.; Brufsky A; Division of Hematology Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.; DeMeo M; Dana-Farber Cancer Institute, Boston, MA.; Vieira JP; Beth Israel Deaconess Medical Center, Boston, MA.; Carey LA; University of North Carolina, Chapel Hill, NC.; Wulf G; Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA.; Domchek S; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA.; Krop IE; Yale Cancer Center, Newhaven, VT.; Wolff AC; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.; Winer EP; Yale Cancer Center, Newhaven, VT.; Garber JE; Harvard Medical School, Boston, MA.; Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Kamihara J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. junne_kamihara@dfci.harvard.edu.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. junne_kamihara@dfci.harvard.edu.; Fisher L; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Schienda J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Vanderwall R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Snir M; Nest Genomics, Wilmington, DE, USA.; Snir G; Nest Genomics, Wilmington, DE, USA.; Simmons E; Nest Genomics, Wilmington, DE, USA.; Khalaj A; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Goler E; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Hamilton KV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Porter CC; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Pencheva B; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Schiffman JD; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Primary Children Hospital, Salt Lake City, UT, USA.; Maese LD; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Primary Children Hospital, Salt Lake City, UT, USA.; Kohlmann W; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Henderson TO; University of Chicago, Chicago, IL, USA.; Lurie Children Hospital, Chicago, IL, USA.; Garber JE; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Diller LR; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Desai AV; University of Chicago, Chicago, IL, USA.; Savage S; Labcorp (formerly Invitae Corporation), San Francisco, CA, USA.; The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.; Klosky JL; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Rana HQ; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: In Process; MEDLINE

Rodriguez-Hernandez A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Harvard Medical School, Boston, MA, United States.; Horiguchi M; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States.; Horton C; Ambry Genetics, Aliso Viejo, CA, United States.; Polfus LM; Ambry Genetics, Aliso Viejo, CA, United States.; Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Buehler RM; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; George S; Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Merriam P; Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Statman MR; Georgetown University Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Sleiman MM Jr; Georgetown University Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Peshkin BN; Georgetown University Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Hamilton JG; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; DeMarco TA; Inova Health System, Fairfax, Virginia, USA.; Rana HQ; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Garber JE; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Sacca R; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Ovadia H; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Isaacs C; Georgetown University Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Tercyak KP; Georgetown University Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.

Publisher: Wiley Country of Publication: England NLM ID: 9214524 Publication Model: Print Cited Medium: Internet ISSN: 1099-1611 (Electronic) Linking ISSN: 10579249 NLM ISO Abbreviation: Psychooncology Subsets: MEDLINE

Lynce F; Dana-Farber/Harvard Cancer Center, Boston, MA, United States.; Graham N; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Kochupurakkal BS; Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, United States.; Nguyen H; Dana-Farber Cancer Institute, Boston, MA, United States.; Bychkovsky B; Dana-Farber Cancer Institute, Boston, MA, United States.; Poorvu PD; Dana-Farber Cancer Institute, Boston, United States.; Attaya V; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Davis R; Dana-Farber Cancer Institute, Boston, MA, United States.; DiLullo M; Dana-Farber Cancer Institute, United States.; D'Andrea AD; Dana-Farber Cancer Institute, Boston, MA, United States.; Garber JE; Dana-Farber Cancer Institute, Boston, MA, United States.; Garg K; Resolution Bioscience, United States.; Lim LP; Resolution Bioscience, United States.; Li M; Resolution Bioscience, United States.; Paweletz CP; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Tayob N; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Shapiro GI; Dana-Farber Cancer Institute, Boston, MA, United States.; Tolaney SM; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Tutt, ANJ; Garber, JE; Kaufman, B; Viale, G; Fumagalli, D; Rastogi, P; Gelber, RD; de, Azambuja E; Fielding, A; Balmaña, J

NEW ENGLAND JOURNAL OF MEDICINE. 384(25):2394-2405

Ongaro G; Salafia C; Sheikh R; Schofield E; Farengo Clark D; Ebrahimzadeh J; Chittenden A; Stopfer JE; Brower J; Symecko H; Ovadia H; Husband A; Barr H; Mukherjee S; Hay JL; Stadler ZK; Offit K; Garber JE; Domchek SM; Robson ME; Hamilton JG

Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Weiss A; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. anna_weiss@urmc.rochester.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. anna_weiss@urmc.rochester.edu.; Harvard Medical School, Boston, MA, USA. anna_weiss@urmc.rochester.edu.; Division of Surgical Oncology, Department of Surgery, University of Rochester, Rochester, NY, USA. anna_weiss@urmc.rochester.edu.; Rosito MS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Braun D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Barton B; Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; McGrath M; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Stokes S; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Laws A; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Warren L; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.; Morganti S; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Lynce F; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bychkovsky B; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rana HQ; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Davis D; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Stopfer J; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Garber JE; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada.; King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Departments of Surgery and Oncology, University of Calgary, Calgary, AB, Canada.

Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Agaoglu NB; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Genetics, Umraniye Training and Research Hospital, İstanbul, Turkey.; Institute of Clinical Cancer Research, Krankenhaus Nordwest, Frankfurt am Main, Germany.; Horton C; Ambry Genetics, Aliso Viejo, California.; Polfus L; Ambry Genetics, Aliso Viejo, California.; Richardson ME; Ambry Genetics, Aliso Viejo, California.; Young C; Ambry Genetics, Aliso Viejo, California.; Scheib R; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Chang KC; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Ave, Boston, MA, 02115, USA.; Silvestri F; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Ave, Boston, MA, 02115, USA.; Oliphant MUJ; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Ave, Boston, MA, 02115, USA.; Martinez-Gakidis MA; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Ave, Boston, MA, 02115, USA.; Orgill DP; Department of Surgery, Division of Plastic and Reconstructive Surgery, Brigham & Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.; Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02115, USA.; Dillon DD; Department of Pathology, Brigham & Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.; Brugge JS; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, 240 Longwood Ave, Boston, MA, 02115, USA. joan_brugge@hms.harvard.edu.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

MS Trivedi; G Samimi; JD Wright; K Holcomb; JE Garber; NS Horowitz; N Arber; E Friedman; RM Wenham; M House; H Parnes; JJ Lee; S Abutaseh; LA Vornik; BM Heckman-Stoddard; PH Brown; KD Crew

Cancer Research. 79:OT2-09

Schneider KA; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Massingham L; Division of Medical Genetics, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI.; The Warren Alpert Medical School of Brown University, Providence, RI.; Weitz M; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Phornphutkul C; Division of Medical Genetics, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI.; The Warren Alpert Medical School of Brown University, Providence, RI.; Leach M; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Gaonkar S; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Schwab J; Division of Medical Genetics, Department of Pediatrics, Hasbro Children's Hospital, Providence, RI.; The Warren Alpert Medical School of Brown University, Providence, RI.; Pepprock H; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Husband A; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Walsh J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Constantine M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Faggen M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Kozyreva O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Kilbridge K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Borden BA; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.; Rodriguez-Hernandez A; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Trottier M; Ambry Genetics, Aliso Viejo, CA, USA.; Horiguchi M; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Weyandt JD; Ambry Genetics, Aliso Viejo, CA, USA.; Horton C; Ambry Genetics, Aliso Viejo, CA, USA.; Polfus LM; Ambry Genetics, Aliso Viejo, CA, USA.; Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Young CC; Ambry Genetics, Aliso Viejo, CA, USA.; Garber JE; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; St Laurent JD; Department of Gynecologic Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, USA.; Rana HQ; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: HumaQ_Rana@dfci.harvard.edu.

Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

Maoz A; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Chen N; Dana-Farber Cancer Institute, Boston, MA.; Boston Children's Hospital, Boston, MA.; Umaretiya P; University of Texas Southwestern Medical Center, Dallas, TX.; Cahill SR; Dana-Farber Cancer Institute, Boston, MA.; Schwartz-Levine A; Dana-Farber Cancer Institute, Boston, MA.; Jagannathan J; Brigham and Women's Hospital, Boston, MA.; Voss SD; Harvard Medical School, Boston, MA.; Boston Children's Hospital, Boston, MA.; Friedman DN; Memorial Sloan Kettering Cancer Center, New York, NY.; Walsh M; Memorial Sloan Kettering Cancer Center, New York, NY.; Robson ME; Memorial Sloan Kettering Cancer Center, New York, NY.; Nehoray B; City of Hope National Medical Center, Duarte, CA.; Frone MN; National Cancer Institute, National Institutes of Health, Rockville, MD.; Schneider KA; Dana-Farber Cancer Institute, Boston, MA.; Schienda JM; Dana-Farber Cancer Institute, Boston, MA.; Boston Children's Hospital, Boston, MA.; Hamilton KV; Dana-Farber Cancer Institute, Boston, MA.; Boston Children's Hospital, Boston, MA.; Onufrychuk A; Dana-Farber Cancer Institute, Boston, MA.; Diller LR; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Boston Children's Hospital, Boston, MA.; Kamihara J; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Boston Children's Hospital, Boston, MA.; Rana HQ; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Garber JE; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; London WB; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Boston Children's Hospital, Boston, MA.; O'Neill AF; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Boston Children's Hospital, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Manning DK; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Ananda G; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Eifert C; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Rojas-Rudilla V; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Swanton W; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Keefe S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Garcia EP; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; D'Eletto M; Knowledge Systems Group, Dana-Farber Cancer Institute, Boston, Massachusetts.; Holdmore E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mishra S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Borziak K; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Lukasse P; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Davineni P; Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Manam MD; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Shivdasani P; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Ghazani AA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Wang AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Bastepe M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Beltran H; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Janeway KA; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Church A; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.; Pollaci A; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chittenden AB; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Koeller DR; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Schwartz Levine A; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Garber JE; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.; Johnson BE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lindeman NI; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Nowak JA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; MacConaill LE; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: laura_macconaill@dfci.harvard.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE

Caron, Olivier; Frebourg, Thierry; Benusiglio, Patrick R.; Foulon, Stéphanie; Brugières, Laurence

JAMA Oncology (JAMA ONCOL), Dec2017; 3(12): 1736-1737. (2p)